#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extra-osseous Ewing's sarcoma Leukocyte adhesion deficiency type I Severe myoclonic epilepsy of infancy Endometrial adenocarcinoma Arterial disorder VEXAS syndrome Leukodystrophy Non-renal cell carcinoma of kidney Prader-Willi syndrome Systemic mastocytosis Hormone-dependent prostate cancer Alveolar rhabdomyosarcoma Aspergillus infection Skin cancer Leukocyte adhesion deficiency More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Life with Disease Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Inclusion body myositis Marginal zone lymphoma refractory – Basic Information Marginal zone lymphoma – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS Short-bowel syndrome – Basic Information Pulmonary sarcoidosis – Basic Information Acute respiratory distress syndrome – Treatment Pituitary-dependent Cushing’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZODASIRAN Dexamethasone Isonicotinate Panitumumab Alendronate Sodium Monohydrate Radium Ra 223 Dichloride Aaa802 Etoposide Gns561 Stiripentol Iomeprol Pervi-Fus Iopromide Danicamtiv Etavopivat Dexamfetamine Sulfate Rizolipase Ivacaftor C1 Esterase Inhibitor (Human) L-LEUCINE Ibrutinib More therapies…

    Learn about Your Condition

    Kidney transplant rejection Ovarian cancer stage IV Intracranial calcification Malignant glioma Glanzmann's disease Mantle cell lymphoma Metastases to rectum Skin neoplasm excision Sjogren's syndrome Haemodialysis Retinopathy of prematurity PIK3CA-activated mutation T-cell lymphoma Arteriovenous malformation Gastrointestinal carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of Autologous Adipose-Derived Stromal Vascular Fraction Cells for Patients with Scarred Vocal Folds

    Recruiting

    2 1
    Investigated Drugs:
    • Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
    • Human Serum Albumin 5%
    • Sodium Chloride
    France

  • Study on Optimizing Initial Dosing of Flucloxacillin and Drug Combination for Critically Ill Patients with Sepsis in the ICU

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Flucloxacillin
    • Meropenem Trihydrate
    • Amoxicillin
    The Netherlands

  • Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Belimumab
    • Fludarabine Phosphate
    • Mycophenolic Acid
    Austria Czechia Denmark France Germany Hungary +7

  • Study on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Saruparib
    • Anastrozole
    • Camizestrant
    Austria Bulgaria Czechia France Germany Hungary +4

  • Study to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies

    Recruiting

    4 1
    Investigated Drugs:
    • Recombinant Human Surfactant Protein-D
    Belgium Czechia France Germany Italy Poland +2

  • Imaging Study with 89Zr-Bevacizumab for Predicting Treatment Effects in Patients with NF2-Related Schwannomatosis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Investigated Drugs:
    • Bevacizumab Zirconium Zr-89
    The Netherlands
Previous Page
1 … 385 386 387 388 389 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!